Medizinische Universität Wien

Diffusion-weighted imaging allows for downgrading mr bi-rads 4 lesions in contrast-enhanced mri of the breast to avoid unnecessary biopsy (2021) Clauser P, Krug B, Bickel H, Dietzel M, Pinker K, Neuhaus VF, Marino MA, et al. Journal article Anaphylaxie im mittleren Lebensalter (2021) Francuzik W, Kraft M, Scherer Hofmeier K, Ruëff F, Pföhler C, Treudler R, Lang R, et al. Journal article Tissue Sodium Concentration Quantification at 7.0-T MRI as an Early Marker for Chemotherapy Response in Breast Cancer: A Feasibility Study (2021) Zaric O, Farr A, Minarikova L, Lachner S, Asseryanis E, Nagel AM, Weber M, et al. Journal article Controlling the Formation of Sodium/Black Phosphorus IntercalationCompounds Towards High Sodium Content (2021) Werbach K, Neiß C, Muellner A, Abellan G, Setman D, Lloret V, Wild S, et al. Journal article An AI classifier derived from 4D radiomics of dynamic contrast-enhanced breast MRI data: potential to avoid unnecessary breast biopsies (2021) Poetsch N, Dietzel M, Kapetas P, Clauser P, Pinker K, Ellmann S, Uder M, et al. Journal article Cost-effectiveness of digital breast tomosynthesis vs. Abbreviated breast mri for screening women with intermediate risk of breast cancer—how low-cost must mri be? (2021) Tollens F, Baltzer PA, Dietzel M, Rübenthaler J, Froelich MF, Kaiser CG Journal article Spartalizumab in metastatic, well/poorly differentiated neuroendocrine neoplasms (2021) Yao JC, Strosberg J, Fazio N, Pavel ME, Bergsland E, Ruszniewski P, Halperin DM, et al. Journal article Health Economic Aspects of Chimeric Antigen Receptor T-cell Therapies for Hematological Cancers: Present and Future (2021) Heine R, Thielen FW, Koopmanschap M, Kersten MJ, Einsele H, Jaeger U, Sonneveld P, et al. Journal article Improving translational research in sex-specific effects of comorbidities and risk factors in ischaemic heart disease and cardioprotection: position paper and recommendations of the ESC Working Group on Cellular Biology of the Heart (2021) Perrino C, Ferdinandy P, Bøtker HE, Brundel BJ, Collins P, Davidson SM, den Ruijter HM, et al. Journal article Elotuzumab, pomalidomide, and dexamethasone is a very well tolerated regimen associated with durable remission even in very advanced myeloma: a retrospective study from two academic centers (2021) Hose D, Schreder M, Hefner J, Bittrich M, Danhof S, Strifler S, Krauth MT, et al. Journal article